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INTRODUCTION
Primary hypothyroidism is a common clinical condition,
complicated by ascites in less than 4% of cases. Myxedema
ascites, caused by hypothyroidism, is also a rare cause of ascites
in less than 1% of new onsets (1). There is often a delay in
diagnosis, and patients may go undiagnosed for a long time
(2). In such cases, the use of thyroid hormone replacement
usually leads to a progressive decrease in ascites, which ulti-
mately disappear (3). Therefore, when any patient presents
with ascites of uncertain etiology, hypothyroidism should be
considered as a differential diagnosis. 
Here, we report a 71-yr-old man with myxedema ascites
that resolved completely with thyroid hormone replacement
therapy. This may be the first case reported in Korea.
CASE REPORT
A 71-yr-old man presented with abdominal distension and
anorexia that had lasted for 10 days. His past medical histo-
ry was unremarkable except for prostate surgery for benign
prostate hyperplasia six years previously. He did not smoke
or drink alcoholic beverages. His blood pressure was 140/90
mmHg, the pulse rate 70 beats/min, and he weighed 55 kg.
The patient was alert and oriented. No jugular vein disten-
sion was found and a cardiopulmonary examination was unre-
markable. The abdomen was markedly distended, with taut
skin and a circumference of 85 cm. There was shifting dull-
ness and fluid waves evident on palpation. There was no pre-
tibial edema. His white blood cell count was 5,500 cells/ L,
hemoglobin was 10.5 g/dL and platelet count was 165,000/
L. The prothrombin time was 11.2 sec (international nor-
malized ratio, INR, 1.0) and the activated partial thrombo-
plastin time was 28 sec. The serum alkaline phosphatase level
was 109 U/L, total bilirubin 1.0 mg/dL, aspartate aminotrans-
ferase (AST) 70 U/L, alanine aminotransferase (ALT) 18 U/L,
amylase 60 mg/dL, and total cholesterol 185 mg/dL. The
total protein level was 5.8 g/dL and albumin 3.3 g/dL. Uri-
nalysis results were normal. Hepatitis B and C serologies were
negative. His initial chest radiograph showed normal with-
out findings of cardiomegaly or pulmonary edema.
Samples of ascitic fluid showed elevated total protein (3.5
g/dL) and a low serum-to-ascites albumin gradient (SAAG;
0.8 g/dL). These were not characteristics of portal hyperten-
sion. The white blood cell count in the fluid was 81/ L, and
84% of the cells were lymphocytes. Gram staining and cytol-
ogy were negative. Bacterial, fungal and mycobacterial cul-
tures were also negative.
Given these negative findings, we performed imaging stud-
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Myxedema Ascites
: Case Report and Literature Review
Myxedema ascites caused by hypothyroidism is rare, so its diagnosis is often delayed
and patients frequently receive unnecessary procedures such as liver biopsies and
exploratory laparotomies. We report a 71-yr-old man with clinical ascites that was
the first manifestation of hypothyroidism, and which resolved completely in response
to thyroid hormone replacement therapy. To our knowledge, this is the first report
of myxedema ascites in Korea. A review of the literature revealed 51 well-document-
ed cases of myxedema ascites. Analyses of ascites from patients in this condition
usually show high protein (>2.5 g/dL) and low white blood cell counts, with a high
proportion of lymphocytes. A consistent feature is the good response to thyroid hor-
mone replacement therapy, which has always led to resolution of the ascites. Myxe-
dema ascites is thus rare but easy to treat; it should be borne in mind, especially if
the ascites fluid has a high protein content. 
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ies to evaluate the possible cause of the ascites. Ultrasonogra-
phy and computed tomography (CT) of the abdomen revealed
massive ascites and a normal-sized liver and spleen (Fig. 1). 
Esophagogastroduodenoscopy (EGD) disclosed no evidence
of portal hypertension such as esophageal varices or gastropa-
thy. A laparoscopic biopsy of the peritoneum and liver was
performed to rule out any common cause of high protein, low
SAAG ascites such as peritoneal malignancies, tuberculosis
or infections. Laparoscopy showed that the surface of the liver
was slightly irregular and the peritoneum was normal in app-
earance. A microscopic examination of the liver biopsy revealed
accumulations of yellow bile pigment in the hepatocytes,
suggesting intrahepatic cholestasis without findings of liver
cirrhosis (Fig. 2). Histology of the peritoneum yielded non-
specific findings. 
We then evaluated the possibility of a cardiogenic origin.
Echocardiography showed normal sized cardiac chambers,
and the patient’s left ventricular ejection fraction was 54%.
However, there was no evidence of congestive heart failure
as the cause of the ascites.
To prevent activation of the renin-angiotensin-aldosterone
system and sodium retention from a vicious cycle of ascites,
we prescribed an aldosterone antagonist (spironolactone 50
mg daily) and an inhibitor of proximal renal tubule sodium
Fig. 1. CT of the abdomen showing massive ascites and normal-
sized liver and spleen.
Fig. 4. Technetium-99m thyroid scan showing only two small nodu-
lar foci in the thyroid bed.
Fig. 2. Microscopic finding of the liver showing accumulation of
yellow bile pigment in the hepatocytes (H&E, ×400). 
Fig. 3. Thyroid ultrasonograph revealing atrophic change of both
thyroid lobes (arrowheads). Myxedema Ascites 763
absorption (furosemide 20 mg daily). However, the patient’s
response to diuretics was poor; his body weight decreased by
only 1 kg and the abdominal circumference by only 2 cm
after diuretic therapy for 10 days.
The patient was discharged with a prescription for 20 mg
furosemide and 50 mg spironolactone daily, because of his
poor financial status. He did not attend the outpatient clinic
for another month, when he was readmitted because of his
increased abdominal girth. Compared with discharge, his
body weight had increased by 3 kg and the abdominal cir-
cumference by 5 cm. The ascitic fluid showed elevated total
protein and a low SAAG value, as found previously. We decid-
ed to evaluate some relatively unusual causes of ascites. We
were interested in the high protein component of the ascites
fluid, so we performed thyroid function testing. These showed
the following values: T3 0.14 nM/L (normal 0.92-2.78 nM/L);
T4 6.0 nM/L (normal 58-140 nM/L); free T4 0.13 pM/L (nor-
mal 10.3-35 pM/L); and thyroid-stimulating hormone level
(TSH) 70.3 mU/L (normal 0.4-5 mU/L). These findings neces-
sitated further thyroid tests. The antimicrosomal antibody
titer was 1:102,400 (normal, <1:100) and the antithyroglob-
ulin antibody titer was negative. Ultrasonography revealed
atrophic change to both thyroid lobes (Fig. 3), and a techne-
tium-99m thyroid scan revealed only two small nodular foci
in the thyroid bed (Fig. 4).
Thyroid hormone replacement therapy was started with
gradually increasing doses of levothyroxine, from 0.05 mg
to 0.15 mg daily to treat the patient’s hypothyroidism. Over
the following three months, he became euthyroid with com-
plete resolution of his ascites, and the liver function tests re-
turned to normal. His body weight decreased by 9 kg and
the abdominal circumference was reduced by 28 cm. There
has been no recurrence of ascites and his euthyroid condition
was maintained over three years of follow-up with levothy-
roxine 0.15 mg daily. The latest follow-up thyroid function
studies showed a free T4 level of 19.3 pM/L and a TSH of 2.7
mU/L.
DISCUSSION
Hypothyroidism is a relatively rare cause of ascites. How-
ever, the importance of its diagnosis is that use of thyroid
hormone replacement results in complete resolution. If there
is new onset ascites, diagnostic workup should begin with
the analysis of ascitic fluid. Usually total protein in the ascitic
fluid and the SAAG value give a useful framework for anal-
ysis of whether the ascitic fluid is a transudate or an exudate.
The total protein in the ascitic fluid was >2.5 g/dL in the
exudate and <2.5 g/dL in the transudate. Of the various caus-
es, peritoneal malignancies, tuberculous peritonitis, pyogenic
peritonitis and pancreatic ascites can all lead to high-protein
ascites. Patients with liver cirrhosis and congestive heart fail-
ure show low protein ascites. The SAAG correlates directly
with portal pressure (4). Ascites fluid associated with portal
hypertension shows a low total albumin level, and the SAAG
is greater than 1.1 g/dL (high gradient) (5, 6). SAAG is usu-
ally high in patients with liver cirrhosis and congestive heart
failure. A gradient of <1.1 g/dL (low) usually suggests that
the ascites is not caused by portal hypertension. The SAAG
is low in patients with peritoneal malignancies, tuberculous
peritonitis, pyogenic peritonitis and pancreatic ascites. There-
fore, a low gradient ascites should initiate an evaluation for
primary peritoneal process, most importantly infections and
malignancies. 
There has been a suggestion that the SAAG may exceed
1.1 in patients with myxedema ascites, based on a review of
eight patients (7). Because so few cases have been studied and
portal hypertension or heart failure do not seem to be the me-
chanisms causing ascites in patients with myxedema, we can-
not conclude that a high SAAG is a typical feature in this
disease (8). Moreover, the patient reported here showed a low
SAAG.
Portal hypertension secondary to liver cirrhosis is the lead-
ing cause of ascites (more than 80% of cases) and peritoneal
involvement in patients with malignant diseases is the sec-
ond at about 10% (9). Therefore, if the composition of ascitic
fluid and ultrasonography are not consistent with portal hyper-
tension or other specific diseases, the physician should con-
sider peritoneal malignancy and perform a peritoneal biop-
sy. If this is negative and the ascitic fluid shows a high pro-
tein content, then hypothyroidism should be considered as
a differential diagnosis. In this patient, because the SAAG
was <1.1 g/dL and there was a lack of esophageal varices or
gastropathy on EGD and characteristic findings on ultrasono-
graphy, there was no evidence of portal hypertension. More-
over, a peritoneal biopsy showed nonspecific findings. As the
ascitic fluid analysis revealed a high protein content, we per-
Number 
of 
patients
Mean Ranges Remarks
Ascites protein  49 3.9 1.8-5.1 Forty-eight patients
(g/dL) (98%) showed 
ascites protein
levels >2.5 g/dL
SAAG (g/dL) 11 1.5 0.8-2.3 Because of the small
number of patients, 
the characteristics 
were unclear
Ascites WBC count 48 60 10-400 Predominance of
(per L) lymphocytes   
(mean 81%)
Duration of ascites  51 8  1 month 
months to 8 yr
Response to treatment 51 Regression of ascites
Table 1. Characteristics of reported patients with myxedema as-
cites
SAAG, serum-to-ascites albumin gradient; WBC, white blood cell.formed thyroid function testing, which proved decisive.
A review of the literature turned up 51 well-documented
cases of myxedema ascites (Table 1) (2, 3, 7, 8, 10-20). A very
consistent finding was the high total protein level (>2.5 g/
dL) (7). Total protein levels exceeded 2.5 g/dL in almost all
cases, with a mean of 3.9 g/dL. The mean SAAG was 1.5 g/
dL with a range of 0.8-2.3 g/dL. White blood cell counts were
rather low, usually with a predominance of lymphocytes; the
mean white blood cell count was 60/ L with a mean of 81%
lymphocytes. In our patient, white blood cell count was 81/
L and lymphocyte proportion, 84%. There was usually a sig-
nificant delay in the diagnosis, with a mean of eight months.
Prompt recognition of myxedema ascites prevents the inap-
propriate use of diuretics and unnecessary procedures, includ-
ing repeated paracenteses, liver biopsies and exploratory laparo-
tomies (10). A constant feature was the good response to thy-
roid hormone replacement therapy, which led to elimination
of the ascites in every instance.
The mechanism of ascites fluid formation in patients with
myxedema is unclear. There are two main hypotheses. The
first is that low levels of circulating thyroid hormones cause
increased extravasation of plasma proteins because of abnor-
mal capillary permeability and the lack of a compensatory
increase in lymph flow and protein return rate (21). The sec-
ond hypothesis is that hyaluronic acid accumulates in the skin
and produces edema by a direct hygroscopic effect. However,
hyaluronic acid has only been found in minute quantities in
patients with myxedema ascites: not large enough to exert a
direct hygroscopic effect. However, it could interact with albu-
min to form complexes that prevent the lymphatic drainage
of extravasated albumin (22).
To our knowledge, this is the first report of myxedema as-
cites in Korea. Although the diagnosis was delayed for about
one and half months, treatment by thyroid hormone replace-
ment medication led to complete regression of the ascites and
normalization of liver function in this patient.
In conclusion, myxedema ascites is rare but easy to treat.
Treatment with thyroid hormone replacement therapy leads
to complete regression of the ascites. A very prominent fea-
ture in such cases is the high total protein level (>2.5 g/dL).
Once routine evaluation of ascites excludes common causes
such as liver cirrhosis, peritoneal malignancies and infections,
congestive heart failure and pancreatic ascites, thyroid func-
tion tests should be performed on patients with high protein
levels in the ascites fluid. 
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